Health-related quality of life and patient-reported symptoms after postoperative proton beam radiotherapy of cervical and endometrial cancer: 2-year results of the prospective phase II APROVE-trial
The APROVE-trial investigated the tolerability of postoperative proton beam therapy in women with cervical or endometrial cancer. The present analysis evaluated the secondary endpoints of health-related quality of life (HRQOL) and patient-reported symptoms.
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
09 January 2023
|
| In: |
Radiation oncology
Year: 2023, Volume: 18, Pages: 1-14 |
| ISSN: | 1748-717X |
| DOI: | 10.1186/s13014-023-02198-4 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s13014-023-02198-4 |
| Author Notes: | Eva Meixner, Antje Wark, Tobias Forster, Fabian Weykamp, Kristin Lang, Laila König, Katja Lindel, Jan Tobias Oelmann-Avendano, Johannes Krisam, Andreas Schneeweiss, Malte Ellerbrock, Thomas Mielke, Juliane Hörner-Rieber, Klaus Herfarth, Jürgen Debus and Nathalie Arians |
| Summary: | The APROVE-trial investigated the tolerability of postoperative proton beam therapy in women with cervical or endometrial cancer. The present analysis evaluated the secondary endpoints of health-related quality of life (HRQOL) and patient-reported symptoms. |
|---|---|
| Item Description: | Gesehen am 21.11.2023 |
| Physical Description: | Online Resource |
| ISSN: | 1748-717X |
| DOI: | 10.1186/s13014-023-02198-4 |